Analysts Estimate Hims & Hers Health, Inc. (HIMS) to Report a Decline in Earnings: What to Look Out for

Core Viewpoint - Hims & Hers Health, Inc. (HIMS) is anticipated to report a year-over-year decline in earnings despite an increase in revenues, which could significantly influence its stock price in the near term [1][2]. Earnings Expectations - The upcoming earnings report is scheduled for February 23, and it may lead to a stock price increase if the results exceed expectations; conversely, a miss could result in a decline [2]. - The consensus estimate for quarterly earnings is projected at $0.02 per share, reflecting a year-over-year decrease of 81.8%. Revenues are expected to reach $619.19 million, marking a 28.7% increase from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 8.51%, indicating a reassessment by analysts regarding the company's earnings outlook [4]. - The Most Accurate Estimate for Hims & Hers Health is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -153.01%, suggesting a bearish sentiment among analysts [12]. Earnings Surprise History - In the last reported quarter, Hims & Hers Health was expected to post earnings of $0.09 per share but only achieved $0.06, resulting in a surprise of -33.33% [13]. - The company has only beaten consensus EPS estimates once in the last four quarters [14]. Conclusion - Hims & Hers Health does not appear to be a strong candidate for an earnings beat, and investors should consider additional factors when making decisions regarding this stock ahead of the earnings release [17].